Photosonix Medical

Photosonix Medical

Signal active

Organization

Contact Information

Overview

Photosonix Medical develops CLENS™ (Coincident Light Energy and Non-focused ultraSound), an energy-based therapy which synergistically combines light and ultrasound to treat chronic bacterial infections known as biofilms. The company targets dermal diseases, specifically moderate to severe acne. Its target prescribers include dermatologists and primary care physicians.

Photosonix Medical is based in Ambler, Pennsylvania.

About

Industries

Biotechnology, Health Care, Medical Device

Founded

2014

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Photosonix Medical headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $63.7M in funding across 36 round(s). With a team of 1-10 employees, Photosonix Medical is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Photosonix Medical, raised $100.0K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Mark Schafer

Mark Schafer

Founder, President & Chief Technology Officer

imagePlace Tessie McNeely

Tessie McNeely

Founder, Vice President & Chief Science Officer

Funding Rounds

Funding rounds

3

Investors

1

Lead Investors

0

Total Funding Amount

$1.8M

Details

1

Photosonix Medical has raised a total of $1.8M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2014Seed100.0K

Investors

Photosonix Medical is funded by 6 investors.

Investor NameLead InvestorFunding RoundPartners
Photosonix Medical-FUNDING ROUND - Photosonix Medical1.7M
Princeton Biopharma Capital Partners-FUNDING ROUND - Princeton Biopharma Capital Partners1.7M
Photosonix Medical-FUNDING ROUND - Photosonix Medical1.7M
Sacha Levy-FUNDING ROUND - Sacha Levy1.7M

Recent Activity

There is no recent news or activity for this profile.